Of the genes that were identified as significant in the combined CML analysis, only AST1 upregulation was significant in blast phase CML samples (Figure 5B, PBlast = 4.8 × 10−2). This evidence concerns the gene GOT1 and chronic myelogenous leukemia, BCR-ABL1 positive.